Nachrichten

According to the WHO news announcement, the monkeypox epidemic has found about 26,000 confirmed cases of monkeypox in more than 88 countries and regions, constituting the highest level of alert of "public health event of international concern (PHEIC)"! This has raised concerns about the spread of the virus. According to the WHO, Europe is currently a high-risk area for monkeypox, and the rest of the world is at a medium-risk level.

Als Reaktion auf den weltweiten Ausbruch von Affen pocken entwickelte Lepu Medical ein Nukleinsäure-Testkit (PCR-Fluoreszenz-Sonde-Methode) für das Monkeypox-Virus und erhielt die EU-CE-Zertifizierung. Dieses Reagenz bietet eine Lösung, um Labors in verschiedenen Ländern dabei zu helfen, Monkeypox-Nukleinsäure tests und eine schnelle Diagnose effizient durch zuführen.

Lepu Medical's monkeypox virus detection kit has the characteristics of high detection sensitivity, easy operability and strong stability. The kit can be quickly applied on multiple platforms such as Lepgen-96, Roche LightCycler 480 series, Bio-Rad CFX96, Shanghai Hongshi SLAN, and ABI 7500. At present, Lepu Medical has received orders and inquiries from many overseas countries and, at the same time, actively promotes the registration of this product in other overseas countries.